40 reports

IV. ALLERGY DRUGS PRODUCTION AND DEMAND

  • Allergy Drug
  • China
  • Industrial Production
  • Labour Force

Abstract: - Global Anti-Allergy Drugs Market to Reach $39.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Anti-Allergy Drugs estimated at US$24.8 Billion in the year 2020, is projected to reach a revised size of US$39.3 Billion by 2027, growing at a CAGR of 6.8% over the analysis period 2020-2027....

  • Allergy Drug
  • World
  • China
  • United States

## Anti-Allergy Drugs

  • Allergy Drug
  • Europe
  • Drug Approval
  • Allergy Prevalence

## Anti-Allergy Drugs

  • Allergy Drug
  • APAC
  • Drug Approval
  • Allergy Prevalence

Figure ##. Anti-Allergy Drugs: Allergy Treatment Market – Revenue and Forecast to 2028 (US$ Million)

  • Allergy Drug
  • APAC
  • Europe
  • World
  • Africa
  • Middle East
  • Central America
  • Allergy Prevalence
  • Drug Approval

## Anti-Allergy Drugs

  • Allergy Drug
  • North America
  • Drug Approval
  • Health Expenditure

Global Allergy Rhinitis Drugs Market 2021-2025 The analyst has been monitoring the allergy rhinitis drugs market and it is poised to grow by $ 2.96 bn during 2021-2025, progressing at a CAGR of about 4% during the forecast period. Our report on allergy rhinitis drugs market provides a holistic analysis, market size and...

  • Allergy Drug
  • Allergy
  • World

III. ALLERGY DRUGS INDUSTRY ASSESSMENTS

  • Allergy Drug
  • Pharmaceutical
  • China
  • Employment Costs
  • Pharmaceutical Production

IV. ALLERGY DRUGS PRODUCTION AND DEMAND

  • Allergy Drug
  • China
  • Labour Force
  • Industrial Production

Abstract: - Global Allergy Treatment Market to Reach $38.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Allergy Treatment estimated at US$27.1 Billion in the year 2020, is projected to reach a revised size of US$38.4 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027....

  • Allergy Drug
  • Food Allergy
  • World
  • China
  • United States

BY ANTI-ALLERGY DRUGS

  • Allergy Drug
  • Food Allergy
  • Therapy
  • Allergy Immunotherapy
  • Europe
  • APAC
  • Africa
  • South Africa
  • Allergy Prevalence
  • Asthma Prevalence

“Peanut Allergy – Pipeline Insight, 2020,” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Allergy
  • Therapy
  • Allergy Drug
  • World

Allergy Treatment Market by Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, and Others), Treatment (Anti-Allergy Drugs and Immunotherapy), Dosage Form (Oral, Inhalers, Intranasal, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Retailers, and Others): Global Opportunity Analysis...

  • Allergy Drug
  • World
  • APAC
  • Allergy Prevalence
  • Biosimilar Penetration Rate

This study covers the world outlook for allergy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative...

  • Allergy Drug
  • World
  • Gross Domestic Product
  • Disposable Income

## Anti-Allergy Drugs

  • Allergy Drug
  • Africa
  • Middle East
  • Drug Approval
  • Allergy Prevalence

## Anti-Allergy Drugs

  • Allergy Drug
  • Central America
  • Drug Approval
  • Allergy Prevalence

United States World Therapy Dermatological Condition Allergy Drug

  • Dermatological Condition
  • Allergy Drug
  • United States
  • World
  • South Korea
  • Indiana
  • Pharmaceutical Registrations
  • Drug Approval

Indiana Dermatological Condition Allergy Drug

  • Dermatological Condition
  • Allergy Drug
  • World
  • South Korea
  • Indiana
  • Pharmaceutical Registrations
  • Drug Approval

World Epidemiology Allergy Drug

  • Respiratory Disease
  • Allergy Drug
  • Epidemiology
  • World
  • Asthma Prevalence
  • Prescription Drug Sales

Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen AllergyDrug Profile

  • Allergy Drug
  • Respiratory Disease
  • World
  • Medicine Use
  • Drug Approval

Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen AllergyDrug Profile

  • Respiratory Disease
  • Allergy Drug
  • World
  • South Korea
  • South Africa
  • Medicine Use
  • Pharmaceutical Registrations

Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen AllergyDrug Profile

  • Respiratory Disease
  • Allergy Drug
  • World
  • Pharmaceutical Registrations
  • Medicine Use

Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Birch Pollen AllergyDrug Profile

  • Allergy Drug
  • Respiratory Disease
  • World
  • Medicine Use

World Asthma Prevalence Allergy Drug Dermatological Condition Food Allergy Respiratory Disease

  • Respiratory Disease
  • Dermatological Condition
  • Allergy Drug
  • Asthma
  • World
  • Asthma Prevalence
  • Allergy Prevalence

Merck ARS Pharmaceuticals, Inc. World Monoclonal Antibody Allergy Drug Arthritis Blood Disease Therapy

  • Therapy
  • Pharmaceutical
  • Allergy Drug
  • Monoclonal Antibody
  • World
  • Hospital Admission
  • Drug Approval

This study covers the latent demand outlook for allergy drugs across the states, union territories, and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 4,900 cities in India. For each city in question, the percent share the city is of its state or...

  • Allergy Drug
  • India
  • United States
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for allergy drugs across the regions of China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang - Tibet), municipalities (Beijing, Chongqing, Shanghai, and Tianjin), special administrative regions (Hong Kong and Macau), and Taiwan (all hereafter referred to...

  • Allergy Drug
  • China
  • Disposable Income
  • Purchasing Power Parity

This study covers the latent demand outlook for allergy drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 12,600 cities in the United States. For each city in question, the percent share the city is of its state...

  • Allergy Drug
  • United States
  • Disposable Income
  • Purchasing Power Parity

Global Allergy Treatment Market: Overview The allergy treatment market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on new treatment development for allergy specific drugs, and increasing prevalence of allergic diseases. The market overview section...

  • Allergy Drug
  • World
  • Allergy Prevalence

Europe Northern Europe Japan United States World Canada Clinical Trial Allergy Drug

  • Allergy Drug
  • Respiratory Disease
  • United States
  • Japan
  • World
  • Asthma Prevalence
  • Health Insurance Coverage